Clinical Trial Update: Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating how sensitive the NIH Toolbox is to stimulant treatment in individuals with intellectual disabilities, including Fragil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Down Syndrome
• Fragile Syndrome
• Intellectual Disability

Snippet

Sponsor: University of California, Davis | Conditions: Intellectual Disability, Fragile X Syndrome | Phase 1 | Status: ENROLLING_BY_INVITATION